AO
Advanced Oncotherapy plc Stock: price and insider trades · United Kingdom
ISIN GB00BD6SX109GB·
No insider purchase over the last 90 days. The latest, by Michael Bradfield, was filed 30 Dec 2022.
Advanced Oncotherapy plc: what insiders have been doing
Every trade that managers of Advanced Oncotherapy plc disclose to RNS (LSE) is tracked on this page. The past year has been quiet: not a single insider filing for Advanced Oncotherapy plc. The previous disclosure was published on 30 December 2022.
Over the whole record (from 2015), the tally stands at 5 purchases and no sales.
These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Insider Decl.
5
Thresholds
n/a
Buy Volume
€337,785
5 ops. · all time
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 30 December 2022
Declarations5 total
- 500,000 sharesLondon Stock ExchangeISIN GB00BD6SX109FCA-NSM:4628674Canonical exit: 29 Mar 2023 (T+90)
- 1,500,000 shares@ £0.0981FCA-NSM:LSE20150608070013_012380156_20200330172147047Canonical exit: 1 Sept 2015 (T+90)
- 1,500,000 shares@ £0.042FCA-NSM:LSE20150205070024_012239259_20200330172135956Canonical exit: 5 May 2015 (T+90)
- 500,000 shares@ £0.041FCA-NSM:LSE20150204085255_012238014_20200330172135925Canonical exit: 4 May 2015 (T+90)
- 500,000 shares@ £0.041FCA-NSM:LSE20150204070020_012237701_20200330172135914Canonical exit: 5 May 2015 (T+90)
5 of 5 declarations
About Advanced Oncotherapy plc
Advanced Oncotherapy plc is a company focused on developing cancer treatment technologies. It specializes in innovation within the field of radiotherapy.
